FRANK WITNEY, PH.D. - Corporate Board Profile

CERUS CORP

Filing Date	Source Excerpt
2014-04-30	Frank Witney, Ph.D., 60, has served as a member of the Board since March 2014. The Nominating and Corporate Governance Committee recommended, and the Board approved, Dr. Witney's appointment to the Board, filling the vacancy left by our former director and Chair of the Board, B.J. Cassin, in part due to his extensive experience in the life science industry, his expertise in corporate strategy and the commercialization of products, and the depth of his scientific background. Dr. Witney has served as President, Chief Executive Officer and a director of Affymetrix, Inc., a provider of life science products and molecular diagnostic products, since July 2011. Dr. Witney served as President and Chief Executive Officer of Dionex Corporation, a provider of analytical instrumentation and related accessories and chemicals, from April 2009 until its acquisition by Thermo Fisher Scientific, Inc. in May 2011. Between December 2008 and April 2009, Dr. Witney served as Affymetrix' Executive Vice President and Chief Commercial Officer. Prior to that, Dr. Witney served as President and Chief Executive Officer of Panomics, Inc. from July 2002 to December 2008. Dr. Witney was a post-doctoral fellow at the National Institutes of Health and holds a Ph.D. in Molecular and Cellular Biology and an M.S. in Microbiology from Indiana University, and B.S. in Microbiology from the University of Illinois. The Board has three standing committees: an Audit Committee, a Compensation Committee and a Nominating and Corporate Governance Committee. The following table provides membership and meeting information for fiscal 2013 for each of the Board committees: Frank Witney: Compensation Committee. The Compensation Committee reviews director compensation on a periodic basis. For the year ended December 31, 2013, the Amended Policy provides that each director, other than the Chair of the Board, who is not also one of our officers or employees, will be compensated for his or her services as a director at the rate of $35,000 per year. The Chair of the Board will receive an annual retainer of $57,500 per year. The annual retainer is paid to our non-employee directors in equal quarterly installments. In addition to the annual retainer, the chairs of the Audit Committee, Compensation Committee and Nominating and Corporate Governance Committees will receive an additional annual retainer of $26,000, $12,500 and $10,000, respectively. Each other member of the Audit Committee, Compensation Committee and Nominating and Corporate Governance Committee who is not one of our employees will receive an annual retainer of $13,000, $8,000 and $6,000, respectively. Frank Witney's total compensation for 2013 was $0 as he joined the Board in March 2014.
2015-04-30	Frank Witney, Ph.D., 61, has served as a member of the Board since March 2014. ... Dr. Witney was appointed to the Board and the Compensation Committee effective March 24, 2014. ... The Audit Committee is currently composed of three directors: Messrs. Anderson, Cozadd (Chair) and Swisher, all of whom were on the Audit Committee for all of 2014. ... The Compensation Committee is currently composed of three directors: Mr. Cozadd, Ms. Schulze (Chair) and Dr. Witney. ... The following table shows for the fiscal year ended December 31, 2014 certain information with respect to the compensation of all non-employee directors of Cerus who served in such capacity during 2014. ... Frank Witney Fees Earned or Paid in Cash($) 37,067 Option Awards($) 200,970 Total($) 238,037.
2016-04-29	Frank Witney, Ph.D., 61, has served as a member of the Board since March 2014. The Compensation Committee is currently composed of three directors: Mr. Cozadd, Ms. Schulze (Chair) and Dr. Witney.
2017-04-28	Frank Witney, Ph.D., 62, has served as a member of the Board since March 2014. ... The Compensation Committee is currently composed of three directors: Mr. Cozadd, Ms. Schulze (Chair) and Dr. Witney, all of whom were on the Compensation Committee for all of 2016. ... For the year ended December 31, 2016, each director, other than the Chair of the Board, who is not also one of our officers or employees, was compensated for his or her services as a director at the rate of $40,000 per year. ... Frank Witney Fees Earned or Paid in Cash($) 48,000, Option Awards($) 61,611, Stock Awards($) 61,609, Total($) 171,220.
2018-04-27	Frank Witney, Ph.D., 64, has served as a member of the Board since March 2014. ... The Audit Committee is currently composed of three directors: Messrs. Anderson, and Swisher and Dr. Witney. ... The Compensation Committee is currently composed of two directors: Ms. Schulze (Chair) and Dr. Witney, both of whom were on the Compensation Committee for all of 2017. ... For the year ended December 31, 2017, each director, who is not also one of our officers or employees, other than the Chair of the Board, was compensated for his or her services as a director at the rate of $40,000 per year. ... Frank Witney received total compensation of $144,197 in 2017.
2019-04-26	Frank Witney, Ph.D., 65, has served as a member of the Board since March 2014. Dr. Witney has served as President, Chief Executive Officer and a director of Affymetrix, Inc., a provider of life science products and molecular diagnostic products, from July 2011 through March 31, 2016, the date it was acquired by Thermo Fisher Scientific, Inc. Dr. Witney served as President and Chief Executive Officer of Dionex Corporation, a provider of analytical instrumentation and related accessories and chemicals, from April 2009 until its acquisition by Thermo Fisher Scientific, Inc. in May 2011. Between December 2008 and April 2009, Dr. Witney served as Affymetrix’s Executive Vice President and Chief Commercial Officer. Prior to that, Dr. Witney served as President and Chief Executive Officer of Panomics, Inc. from July 2002 to December 2008. Dr. Witney was a post-doctoral fellow at the National Institutes of Health and holds a Ph.D. in Molecular and Cellular Biology and an M.S. in Microbiology from Indiana University, and B.S. in Microbiology from the University of Illinois.
2020-04-24	Frank Witney, Ph.D., 66, has served as a member of the Board since March 2014. ... The Board has three standing committees: an Audit Committee, a Compensation Committee and a Nominating and Corporate Governance Committee. ... The following table provides membership and meeting information for fiscal 2019 for each of the Board committees: Frank Witney - Audit Committee, Compensation Committee. ... The following table shows for the fiscal year ended December 31, 2019 certain information with respect to the compensation of all non-employee directors of Cerus who served in such capacity during 2019. Frank Witney compensation: $168,434.
2021-04-23	Frank Witney, Ph.D., 67, has served as a member of our Board since March 2014... The Audit Committee is currently composed of three directors: Dr. Witney (Chair), Mr. Anderson and Ms. Nachtsheim... The Compensation Committee is currently composed of four directors: Ms. Schulze (Chair), Dr. Witney, and Messrs. Swisher and Moore... The following table shows for the fiscal year ended December 31, 2020 certain information with respect to the compensation of all non-employee directors of Cerus who served in such capacity during 2020... Frank Witney Fees Earned or Paid in Cash($) 66,000, Option Awards($) 87,938, Stock Awards($) 84,262, Total($) 238,200.
2022-04-22	Frank Witney, Ph.D., 68, has served as a member of our Board since March 2014... The Audit Committee is currently composed of four directors: Dr. Witney (Chair), Ms. Lucena, Mr. Bjerkholt, and Mr. Swisher... The Compensation Committee is currently composed of three directors: Ms. Schulze (Chair), Dr. Witney, and Mr. Moore... The Nominating and Corporate Governance Committee currently consists of three directors: Mss. Nachtsheim (Chair) and Schulze, and Mr. Swisher... The following table shows for the fiscal year ended December 31, 2021 certain information with respect to the compensation of all non-employee directors of Cerus who served in such capacity during 2021... Frank Witney: Fees Earned or Paid in Cash $78,278, Option Awards $83,674, Stock Awards $83,671, Total $245,623.
2023-04-28	Frank Witney, Ph.D., 69, has served as a member of our Board since March 2014. The Compensation Committee is currently composed of three directors: Ms. Schulze (Chair), Dr. Witney, and Mr. Moore, all of whom were on the Compensation Committee for all of 2022. The Audit Committee met four times during the fiscal year.
2024-04-26	Frank Witney, Ph.D., 70, has served as a member of our Board since March 2014. ... Under our director compensation program in effect for 2023, each non-employee director was entitled to an annual grant of RSUs on the date of each of our annual meetings ... each of our non-employee directors other than Dr. Shan received an RSU grant covering 40,000 shares on the date of the 2023 Annual Meeting. ... The number of shares subject to the RSU awards was determined in 2023 by dividing the target dollar value ($200,000) by a price of $5.00 per share ... The aggregate grant date fair value of the annual RSU awards for 2023 granted on June 7, 2023, calculated in accordance with Topic 718 ... The total for Dr. Witney is $167,600.